* 中国生物科技公司--百奥赛图2315.HK周四早盘高开0.6%，随后涨幅扩大至7.1%，创2022年上市以来新高。
* 该公司此前公告称，建议A股发行及于上交所科创板上市已获上交所科创板上市委员会批准。
* 百奥赛图今年迄今暴涨243.5%，同期恒生指数.HSI大幅上扬32.1%。
* 恒生生物科技指数.HSBIO盘中一度升1.5%。
* 百奥赛图搜集了各种有潜力用于治疗癌症的抗体分子，其他生物科技公司可以从中挑选并购买，以节省研发成本。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 杨淑祯)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.